Education
About Us
Working with TipRanks
Follow Us
Fevertree Drinks (FQVTF)
OTHER OTC:FQVTF
FQVTF Analyst Ratings
Hold
0 Buy
8 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FQVTF Stock 12 Month Forecast
Average Price Target
$10.35
▼(-0.67% Downside)
| Highest Price Target$16.41 | Average Price Target$10.35 | Lowest Price Target$7.66 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
Reiterated
03/27/25
Berenberg Bank
Reiterated
03/26/25
Barclays
Reiterated
03/26/25
J.P. Morgan
Reiterated
02/28/25
Deutsche Bank
Downgraded
02/10/25
Morgan Stanley
Reiterated
02/06/25
Redburn Atlantic
Downgraded
02/04/25
Goldman Sachs
Upgraded
01/31/25
Bank of America Securities
Reiterated
01/14/25
HSBC
$14.24
Buy
36.66%
Upside
Reiterated
12/02/24
HSBC Reiterates Buy Rating on Fevertree Drinks Plc. (FEVR:LN) (FQVTF)HSBC analyst Doriana Russo reiterated a Buy rating and GBP11.00 price target on Fevertree Drinks Plc. (FEVR:LN) (OTC: FQVTF).
Exane BNP Paribas
$10.36
Hold
-0.61%
Downside
Downgraded
10/10/24
Fevertree Drinks downgraded to Neutral from Outperform at Exane BNP ParibasFevertree Drinks downgraded to Neutral from Outperform at Exane BNP Paribas
RBC Capital
$12.95
Hold
24.24%
Upside
Reiterated
09/12/24
RBC Capital Reaffirms Their Hold Rating on Fevertree Drinks (FQVTF)
Stifel Nicolaus
$1,838.26→$18.51
Buy
77.66%
Upside
Reiterated
04/02/24
Fevertree Drinks Plc. (FEVR:LN) (FQVTF) PT Raised to GBP14.30 at StifelThe analyst commented: 'FT says it is on track to double EBITDA in FY24 (following a soft FY23). Margin recovery seems to be playing out, as glass and freight cost headwinds ease. We upgrade our FY24-25 EBITDA estimates by 2-4%. US revenue grew 24% in FY23 and we model 18% growth in FY24. Mid-term On/Off-Trade distribution targets seem compatible with our US scenario analysis, for base case revenue of £420m and £63m by 2030. Valuation relative to near-term earnings is not obviously attractive. But our 1430p TP (from 1420p) tries to reflect US potential at maturity, offering ~20% upside potential.<br />We remain Buy rated.'
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
Reiterated
03/27/25
Berenberg Bank
Reiterated
03/26/25
Barclays
Reiterated
03/26/25
J.P. Morgan
Reiterated
02/28/25
Deutsche Bank
Downgraded
02/10/25
Morgan Stanley
Reiterated
02/06/25
Redburn Atlantic
Downgraded
02/04/25
Goldman Sachs
Upgraded
01/31/25
Bank of America Securities
Reiterated
01/14/25
HSBC
$14.24
Buy
36.66%
Upside
Reiterated
12/02/24
HSBC Reiterates Buy Rating on Fevertree Drinks Plc. (FEVR:LN) (FQVTF)HSBC analyst Doriana Russo reiterated a Buy rating and GBP11.00 price target on Fevertree Drinks Plc. (FEVR:LN) (OTC: FQVTF).
Exane BNP Paribas
$10.36
Hold
-0.61%
Downside
Downgraded
10/10/24
Fevertree Drinks downgraded to Neutral from Outperform at Exane BNP ParibasFevertree Drinks downgraded to Neutral from Outperform at Exane BNP Paribas
RBC Capital
$12.95
Hold
24.24%
Upside
Reiterated
09/12/24
RBC Capital Reaffirms Their Hold Rating on Fevertree Drinks (FQVTF)
Stifel Nicolaus
$1,838.26→$18.51
Buy
77.66%
Upside
Reiterated
04/02/24
Fevertree Drinks Plc. (FEVR:LN) (FQVTF) PT Raised to GBP14.30 at StifelThe analyst commented: 'FT says it is on track to double EBITDA in FY24 (following a soft FY23). Margin recovery seems to be playing out, as glass and freight cost headwinds ease. We upgrade our FY24-25 EBITDA estimates by 2-4%. US revenue grew 24% in FY23 and we model 18% growth in FY24. Mid-term On/Off-Trade distribution targets seem compatible with our US scenario analysis, for base case revenue of £420m and £63m by 2030. Valuation relative to near-term earnings is not obviously attractive. But our 1430p TP (from 1420p) tries to reflect US potential at maturity, offering ~20% upside potential.<br />We remain Buy rated.'
FQVTF Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
1
1
1
1
0
Hold
9
3
4
6
9
Sell
1
0
1
2
2
Strong Sell
0
0
0
0
0
total
11
4
6
9
11
Each month's total comprises the sum of three months' worth of ratings.
FQVTF Financial Forecast
FQVTF Stock Forecast FAQ
What is FQVTF’s average 12-month price target, according to analysts?
Based on analyst ratings, Fevertree Drinks’s 12-month average price target is $10.35.
What is FQVTF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for FQVTF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FQVTF a Buy, Sell or Hold?
Fevertree Drinks has a consensus rating of Hold which is based on 0 buy ratings, 8 hold ratings and 2 sell ratings.
What is Fevertree Drinks’s price target?
The average price target for Fevertree Drinks is $10.35. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $16.41 ,the lowest forecast is $7.66. The average price target represents -0.67% Decrease from the current price of $10.42.
The highest analyst price target is $16.41 ,the lowest forecast is $7.66. The average price target represents -0.67% Decrease from the current price of $10.42.
What do analysts say about Fevertree Drinks?
Fevertree Drinks’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of FQVTF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.